Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): results from a double-blind, randomised, phase 3 trial
| Title | Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): results from a double-blind, randomised, phase 3 trial |
|---|---|
| Description | The article will be published in The Lancet. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA010775 |
| Release Date | 2022-12-31 |
| Submitter | JIAN HUANG (hjgcp2017@163.com) |
| Organization | Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| Submission Date | 2022-10-12 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002039-02 | CM914 Results in The Lancet | 1 | Biomarker Data | 537.0 KB | rar | 0 | Controlled |